Abstract:Precisely controlling the interaction of nanoparticles with biological systems (nanobio interactions) from the injection site to biological targets shows great potential for biomedical applications. Inspired by the ability of nanoparticles to alter, their physicochemical properties according to different stimuli, we-explored the tumor acidity and near-infrared (NIR) light activated transformable nanoparticle (DA)TAT-NPIR&DOX. This nanoparticle consists of a tumor acidity-activated TAT [the TAT lysine residues' amines was modified with 2,3-dimethylmaleic anhydride (DA)], a flexible chain polyphosphoester core coencapsulated a NIR dye IR-780, and DOX (doxorubicin): The physicochemical properties of the nanoparticle can be controlled in a stepwise fashion using tumor acidity and NIR light, resulting in adjustable nanobio interactions. The resulting transformable nanoparticle (DA)TAT-NPIR&DOX efficiently avoids the interaction with mononuclear phagocyte system (MPS) ("stealth" state) due to the masking of the TAT peptide during blood circulation. Once it has accumulated in the tumor tissues, (DA)TAT-NPIR&DOX is reactivated by tumor acidity and transformed into the "recognize" state in order. to promote interaction with tumor cells and enhance cellular internalization. Then, this nanoparticle is transformed into "attack" state under NIR irradiation, achieving the-supersensitive DOX release from the flexible chain polyphosphoester :core in order to increase the DOX-DNA interaction. This concept provides new avenues for the creation of transformable drug delivery systems that have the ability to control nanobio interactions.

<i>In situ</i> formation of J-aggregate in the tumor microenvironment using acidity responsive polypeptide nanoparticle encapsulating galactose-conjugated BODIPY dye for NIR-II phototheranostics (vol,10,pg,5279,2022)

Correction: in Situ Formation of J-aggregate in the Tumor Microenvironment Using Acidity Responsive Polypeptide Nanoparticle Encapsulating Galactose-Conjugated BODIPY Dye for NIR-II Phototheranostics.

In Situ Formation of J-aggregate in the Tumor Microenvironment Using Acidity Responsive Polypeptide Nanoparticle Encapsulating Galactose-Conjugated BODIPY Dye for NIR-II Phototheranostics

Novel near-infrared II aggregation-induced emission dots for <i>in vivo</i> bioimaging (vol 10, 1219, 2019)

Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Correction: Novel Near-Infrared II Aggregation-Induced Emission Dots for in Vivo Bioimaging

Ph and Glutathione Synergistically Triggered Release and Self-Assembly of Au Nanospheres for Tumor Theranostics.

In Situ Catalytic Reaction for Solving the Aggregation of Hydrophobic Photosensitizers in Tumor

Correction: Near-infrared light triggered photothermal therapy and enhanced photodynamic therapy with a tumor-targeting hydrogen peroxide shuttle

Correction: Facile synthesis of near-infrared bodipy by donor engineering for in vivo tumor targeted dual-modal imaging

Correction: Photodynamic antitumor activity of aggregation-induced emission luminogens as chemosensitizers for paclitaxel by concurrent induction of apoptosis and autophagic cell death

In Situ Construction and Characterization of Chlorin-Based Supramolecular Aggregates in Tumor Cells

Correction: an Oxygen Self-Sufficient NIR-responsive Nanosystem for Enhanced PDT and Chemotherapy Against Hypoxic Tumors

Metal ions-bridged J-aggregation mediated nanoassembly composition for breast cancer phototherapy

Morphology Tuning of Aggregation-Induced Emission Probes by Flash Nanoprecipitation: Shape and Size Effects on in Vivo Imaging.

J-aggregation induced NIR-II fluorescence: an aza-BODIPY luminogen for efficient phototheranostics

Correction: Radiopharmaceutical-activated silicon naphthalocyanine nanoparticles towards tumor photodynamic therapy

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Tumor Acidity/NIR Controlled Interaction of Transformable Nanoparticle with Biological Systems for Cancer Therapy

Correction to "Conjugated Coordination Porphyrin-based Nanozymes for Photo-/Sono-Augmented Biocatalytic and Homologous Tumor Treatments"

J‐Aggregate Promoting NIR‐II Emission for Fluorescence/ Photoacoustic Imaging‐Guided Phototherapy